2021 Exhibitor List X Showroom

Dongkook Pharmaceutical was founded in 1968 and from the early stage since its foundation, Dongkook has concentrated on R&D and technology innovation. We, Dongkook Pharmaceutical is well known for its OTC products boasting of high brand values in Korea. Besides OTC products, Dongkook has developed and produced outstanding therapeutic products through various clinical trials, e.g. Pofol Injection, intravenous anesthetic agent, and Lorelin Depot, an anti-cancer agent, earning raves in both domestic and overseas markets. Dongkook completed its registration in PMDA of Japan regarding GMP approval and product registration for the finished product such as Antibiotic agent, and anesthetic agent, and Teicoplanin acquired COS(Certificate of Suitability) in 2009 from EDQM. Currently, Dongkook Pharmaceutical exports finished pharmaceutical products and API to over 50 countries around the world. It seeks to grow into a global leading pharmaceutical company that is trusted and loved by all domestic and overseas customers backed by the greatest global competitiveness.